Tag: mRNA cancer vaccine
3 predictions tagged with "mRNA cancer vaccine".
Personalized MRNA Cancer Vaccines Are Expected To Show Promising Phase 3 Trial Results.2027 · Health
Moderna And Merck's Personalized MRNA Neoantigen Cancer Vaccine Intismeran Autogene (V940/mRNA-4157) Is Expected To Receive Its First Regulatory Approval In 2028 As Adjuvant Treatment For High-risk Melanoma.2028 · Health
The Personalized MRNA Cancer Vaccine From Moderna And Merck (Intismeran Combined With Keytruda) Will Receive Its First Approval From A Major Regulator (FDA Or EMA).2029 · Health
